Victoria Nicole Parikh, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Parikh’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A125191 · Current
Licensed to practise in California · since 2013 · expires 2028-05-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$20,325
Medicare paid this office $20,325 for 409 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 21 | $2,853 | $124 |
| Return visit (30+ min) | 29 | $2,489 | $75 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $2,195 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 251 | $1,982 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,628 | $71 |
See all 11 services
| Return visit (30+ min) | 21 | $2,853 | $124 |
| Return visit (30+ min) | 29 | $2,489 | $75 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $2,195 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 251 | $1,982 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,628 | $71 |
| Long return visit (40+ min) | 13 | $1,566 | $120 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,413 | $74 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $806 | $73 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 35 | $798 | $23 |
| Test for exercise-induced heart and lung stress | 13 | $720 | $55 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $586 | $23 |
Who their Medicare patients are
409 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 17% · Women 55% · Also on Medicaid 34% · Health risk score 2.43. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Heart failure 50% · Coronary heart disease 49% · Atrial fibrillation 47% · Chronic kidney disease 45% · Diabetes 38% · Depression 30% · Cancer 24% · COPD 24% · Stroke 21% · Dementia 19%.
The office billed $105,386, Medicare allowed $26,478 and paid $20,325; for 560 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 409 | 560 | 74 | 2.43 | $105,386 | $20,325 |
| 2023 | 289 | 431 | 75 | 2.03 | $99,719 | $24,866 |
| 2022 | 349 | 548 | 74 | 2.03 | $124,425 | $27,349 |
| 2021 | 360 | 531 | 75 | 1.83 | $109,069 | $23,540 |
| 2020 | 126 | 218 | 72 | 1.94 | $70,845 | $15,939 |
| 2019 | 139 | 238 | 73 | 2.07 | $41,296 | $13,083 |
| 2018 | 59 | 120 | 71 | 2.07 | $24,705 | $10,499 |
| 2017 | 29 | 52 | 74 | 1.58 | $15,390 | $4,883 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Long return visit (40+ min) | 26 | $3,614 | $134 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 53 | $3,432 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,772 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,272 | $120 |
| New patient visit (60+ min) | 13 | $2,171 | $167 |
| Return visit (30+ min) | 18 | $1,558 | $78 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,442 | $76 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,436 | $76 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,392 | $107 |
| Test for exercise-induced heart and lung stress | 15 | $931 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 105 | $928 | $7 |
| Short return visit (20+ min) | 11 | $732 | $56 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $215 | $20 |
2022: 13 services
| Long return visit (40+ min) | 29 | $4,271 | $133 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 50 | $3,612 | $34 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,461 | $91 |
| Return visit (30+ min) | 22 | $2,004 | $84 |
| New patient visit (60+ min) | 11 | $1,953 | $178 |
| Short return visit (20+ min) | 21 | $1,472 | $61 |
| Test for exercise-induced heart and lung stress | 23 | $1,450 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,434 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,347 | $122 |
| Initial hospital observation care per day, typically 30 minutes | 15 | $1,206 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 142 | $1,193 | $8 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,003 | $67 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 34 | $867 | $25 |
2021: 10 services
| New patient visit (60+ min) | 15 | $2,622 | $175 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $2,580 | $92 |
| Return visit (30+ min) | 26 | $2,541 | $88 |
| Long return visit (40+ min) | 16 | $2,478 | $124 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,840 | $35 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 193 | $1,773 | $8 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,312 | $66 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 41 | $1,011 | $25 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $996 | $66 |
| Hospital observation care on day of discharge | 12 | $815 | $68 |
2020: 6 services
| Long return visit (40+ min) | 25 | $2,528 | $90 |
| New patient visit (60+ min) | 11 | $1,679 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,383 | $92 |
| Return visit (30+ min) | 17 | $1,246 | $69 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 38 | $923 | $24 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $684 | $36 |
2019: 4 services
| Long return visit (40+ min) | 24 | $2,928 | $98 |
| Return visit (30+ min) | 21 | $1,794 | $72 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 68 | $563 | $8 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 15 | $466 | $25 |
2018: 2 services
| Long return visit (40+ min) | 21 | $2,993 | $97 |
| New patient visit (60+ min) | 16 | $2,324 | $145 |
Medicaid work
$1,858 in 2024
Medicaid paid $1,858 for 194 billed services this clinician did in 2024, up to 118 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 194 | $1,858 |
| 2024 | 194 | 1 | 118 | $1,858 |
| 2023 | 108 | 1 | 102 | $977 |
| 2022 | 183 | 2 | 113 | $1,679 |
| 2021 | 137 | 1 | 54 | $1,242 |
| 2019 | 45 | 1 | 39 | $436 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 108 | $977 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 153 | $1,246 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 30 | $432 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 137 | $1,242 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 45 | $436 |
Drugs they prescribed that Part D paid
$557,883
Pharmacies billed $557,883 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 830) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
594 generic and 236 brand-name prescriptions · $557,883 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Camzyos | 36 | $300,845 | $8,357 |
| Entresto | 85 | $106,511 | $1,253 |
| Eliquis | 48 | $59,038 | $1,230 |
| Jardiance | 29 | $41,429 | $1,429 |
| Farxiga | 13 | $16,911 | $1,301 |
See all 17 drugs
| Camzyos | 36 | $300,845 | $8,357 |
| Entresto | 85 | $106,511 | $1,253 |
| Eliquis | 48 | $59,038 | $1,230 |
| Jardiance | 29 | $41,429 | $1,429 |
| Farxiga | 13 | $16,911 | $1,301 |
| Metoprolol | 103 | $1,709 | $17 |
| Carvedilol | 125 | $943 | $8 |
| Ezetimibe | 23 | $815 | $35 |
| Valsartan | 23 | $629 | $27 |
| Atorvastatin | 58 | $485 | $8 |
| Diltiazem 24hr Er (Cd) | 12 | $465 | $39 |
| Losartan | 38 | $276 | $7 |
| Rosuvastatin | 25 | $227 | $9 |
| Spironolactone | 37 | $221 | $6 |
| Amlodipine Besylate | 28 | $174 | $6 |
| Lisinopril | 15 | $80 | $5 |
| Furosemide | 24 | $78 | $3 |
Year by year
| 2024 | 830 | 124 | 0% (0) | 28% | $557,883 |
| 2023 | 701 | 116 | 0% (0) | 27% | $351,732 |
| 2022 | 603 | 105 | 0% (0) | None | $100,147 |
| 2021 | 491 | 83 | 0% (0) | 15% | $67,175 |
| 2020 | 544 | 84 | 0% (0) | 19% | $75,763 |
| 2019 | 321 | 60 | 0% (0) | 16% | $37,563 |
| 2018 | 205 | 40 | 0% (0) | 20% | $26,052 |
| 2017 | 56 | 21 | 0% (0) | 34% | $9,692 |
| 2016 | 12 | None | 0% (0) | None | $2,725 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Camzyos | 21 | $167,849 | $7,993 |
| Entresto | 63 | $70,864 | $1,125 |
| Eliquis | 66 | $53,213 | $806 |
| Jardiance | 15 | $22,277 | $1,485 |
| Xarelto | 12 | $11,549 | $962 |
| Metoprolol | 95 | $2,650 | $28 |
| Diltiazem 24hr Er (Cd) | 11 | $1,119 | $102 |
| Carvedilol | 60 | $707 | $12 |
| Atorvastatin | 46 | $704 | $15 |
| Rosuvastatin | 35 | $584 | $17 |
| Ezetimibe | 15 | $582 | $39 |
| Amlodipine Besylate | 39 | $568 | $15 |
| Losartan | 27 | $555 | $21 |
| Valsartan | 20 | $425 | $21 |
| Spironolactone | 36 | $299 | $8 |
| Furosemide | 25 | $203 | $8 |
| Lisinopril | 20 | $95 | $5 |
2022: 17 drugs
| Eliquis | 37 | $28,865 | $780 |
| Entresto | 37 | $28,116 | $760 |
| Jardiance | 12 | $12,493 | $1,041 |
| Brilinta | 12 | $7,185 | $599 |
| Metoprolol | 69 | $2,042 | $30 |
| Rosuvastatin | 33 | $924 | $28 |
| Carvedilol | 61 | $718 | $12 |
| Atorvastatin | 49 | $585 | $12 |
| Amlodipine Besylate | 32 | $425 | $13 |
| Isosorbide Mononitrate Er | 11 | $318 | $29 |
| Diltiazem 24hr Er (Cd) | 15 | $316 | $21 |
| Losartan | 31 | $254 | $8 |
| Ezetimibe | 13 | $184 | $14 |
| Furosemide | 23 | $174 | $8 |
| Spironolactone | 35 | $122 | $3 |
| Lisinopril | 12 | $78 | $6 |
| Hydrochlorothiazide | 17 | $41 | $2 |
2021: 12 drugs
| Eliquis | 39 | $35,020 | $898 |
| Entresto | 11 | $7,972 | $725 |
| Metoprolol | 55 | $1,226 | $22 |
| Losartan | 24 | $649 | $27 |
| Carvedilol | 59 | $635 | $11 |
| Atorvastatin | 39 | $617 | $16 |
| Isosorbide Mononitrate Er | 25 | $539 | $22 |
| Diltiazem 24hr Er (Cd) | 13 | $502 | $39 |
| Rosuvastatin | 25 | $228 | $9 |
| Amlodipine Besylate | 25 | $129 | $5 |
| Spironolactone | 19 | $85 | $4 |
| Furosemide | 24 | $56 | $2 |
2020: 12 drugs
| Eliquis | 37 | $31,268 | $845 |
| Entresto | 30 | $18,367 | $612 |
| Metoprolol | 72 | $1,256 | $17 |
| Atorvastatin | 35 | $591 | $17 |
| Isosorbide Mononitrate Er | 21 | $442 | $21 |
| Carvedilol | 47 | $407 | $9 |
| Rosuvastatin | 20 | $374 | $19 |
| Spironolactone | 33 | $316 | $10 |
| Amlodipine Besylate | 36 | $252 | $7 |
| Losartan | 27 | $246 | $9 |
| Verapamil Er | 13 | $195 | $15 |
| Amiodarone | 15 | $169 | $11 |
2019: 8 drugs
| Eliquis | 24 | $16,185 | $674 |
| Xarelto | 14 | $8,494 | $607 |
| Metoprolol | 43 | $921 | $21 |
| Amiodarone | 18 | $440 | $24 |
| Atorvastatin | 19 | $425 | $22 |
| Amlodipine Besylate | 27 | $366 | $14 |
| Carvedilol | 26 | $289 | $11 |
| Losartan | 16 | $121 | $8 |
2018: 6 drugs
| Eliquis | 12 | $8,916 | $743 |
| Xarelto | 12 | $8,592 | $716 |
| Brilinta | 12 | $4,853 | $404 |
| Metoprolol | 29 | $654 | $23 |
| Isosorbide Mononitrate Er | 15 | $447 | $30 |
| Atorvastatin | 35 | $377 | $11 |
Money from drug and device companies
$5,000 in 2023
| 2023 | 1 | 2 | $5,000 | $5,000 |
| 2022 | 2 | 2 | $1,593 | $1,593 |
| 2021 | 1 | 2 | $1,000 | $1,000 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| BioMarin Pharmaceutical | None | $5,000 | 2 payments
|
See all 2 published payments
| BioMarin Pharmaceutical | Paid to speak or teach · 2023-07-10 | None | $4,250 |
| BioMarin Pharmaceutical | Paid to speak or teach · 2023-04-14 | None | $750 |
See earlier years (2022, 2021)
2022: $1,593
| BioMarin Pharmaceutical | None | $1,000 | 1 payment
|
| Viz.ai | Viz.Ai Lvo | $593 | 1 payment
|
2021: $1,000
| BioMarin Pharmaceutical | None | $1,000 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| PFIZER INC. · Genetic Heritable Heart Disease Registry Consortium · 2023 | Their institution | $29,343 |
| BioMarin Pharmaceutical Inc. · 2021 | Their institution | $26,460 |
Professional record
- NPI
- 1679862411
- Licence
- CA A125191California A125191: Current · expires 2028-05-31
- Trained
- Stanford University School of Medicine, 2011
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-04-01
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.